In last trading session, Traws Pharma Inc (NASDAQ:TRAW) saw 0.51 million shares changing hands with its beta currently measuring 1.12. Company’s recent per share price level of $1.19 trading at $0.09 or 8.18% at ring of the bell on the day assigns it a market valuation of $6.35M. That closing price of TRAW’s stock is at a discount of -1533.61% from its 52-week high price of $19.44 and is indicating a premium of 18.49% from its 52-week low price of $0.97. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.19 million shares which gives us an average trading volume of 101.35K if we extend that period to 3-months.
Traws Pharma Inc (NASDAQ:TRAW) trade information
Upright in the green during last session for gaining 8.18%, in the last five days TRAW remained trading in the red while hitting it’s week-highest on Tuesday, 05/13/25 when the stock touched $1.19 price level, adding 22.73% to its value on the day. Traws Pharma Inc’s shares saw a change of -86.60% in year-to-date performance and have moved -10.53% in past 5-day. Traws Pharma Inc (NASDAQ:TRAW) showed a performance of -40.20% in past 30-days. Number of shares sold short was 73982.0 shares which calculate 1.25 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 42.51% during past 5 years.
Traws Pharma Inc (NASDAQ:TRAW)’s Major holders
Insiders are in possession of 19.67% of company’s total shares while institution are holding 32.57 percent of that, with stock having share float percentage of 40.55%. Investors also watch the number of corporate investors in a company very closely, which is 32.57% institutions for Traws Pharma Inc that are currently holding shares of the company.
On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 17.01 shares of worth $20243.0 or 0.32% of the total outstanding shares. The later fund manager was in possession of 12.88 shares on Dec 31, 2024 , making its stake of worth around $15326.0 in the company or a holder of 0.24% of company’s stock.
